nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—FMO3—Nicotine Metabolism—CYP2A6—hepatitis B	0.0218	0.121	CbGpPWpGaD
Voriconazole—FMO1—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0112	0.0622	CbGpPWpGaD
Voriconazole—FMO3—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00802	0.0445	CbGpPWpGaD
Voriconazole—CYP2B6—Nicotine Metabolism—CYP2A6—hepatitis B	0.00654	0.0363	CbGpPWpGaD
Voriconazole—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00637	0.00813	CcSEcCtD
Voriconazole—Raised liver function tests—Lamivudine—hepatitis B	0.00627	0.008	CcSEcCtD
Voriconazole—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.0061	0.00779	CcSEcCtD
Voriconazole—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.006	0.00765	CcSEcCtD
Voriconazole—Chest discomfort—Telbivudine—hepatitis B	0.00581	0.00741	CcSEcCtD
Voriconazole—Cardiomyopathy—Lamivudine—hepatitis B	0.00566	0.00722	CcSEcCtD
Voriconazole—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00551	0.00703	CcSEcCtD
Voriconazole—Gingival bleeding—Lamivudine—hepatitis B	0.0051	0.00651	CcSEcCtD
Voriconazole—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00507	0.00647	CcSEcCtD
Voriconazole—Hepatic failure—Entecavir—hepatitis B	0.00505	0.00645	CcSEcCtD
Voriconazole—Influenza like illness—Telbivudine—hepatitis B	0.00499	0.00637	CcSEcCtD
Voriconazole—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00493	0.00629	CcSEcCtD
Voriconazole—Anaphylactoid reaction—Entecavir—hepatitis B	0.00469	0.00599	CcSEcCtD
Voriconazole—PTGS1—Eicosanoid Synthesis—GGT2—hepatitis B	0.00467	0.0259	CbGpPWpGaD
Voriconazole—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00466	0.00594	CcSEcCtD
Voriconazole—Respiratory tract infection—Lamivudine—hepatitis B	0.00461	0.00588	CcSEcCtD
Voriconazole—Sepsis—Telbivudine—hepatitis B	0.00446	0.00569	CcSEcCtD
Voriconazole—Bone marrow depression—Lamivudine—hepatitis B	0.00429	0.00547	CcSEcCtD
Voriconazole—Blood creatinine increased—Entecavir—hepatitis B	0.00425	0.00543	CcSEcCtD
Voriconazole—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00421	0.00537	CcSEcCtD
Voriconazole—CYP3A5—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.0042	0.0233	CbGpPWpGaD
Voriconazole—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00415	0.0053	CcSEcCtD
Voriconazole—Myopathy—Lamivudine—hepatitis B	0.00413	0.00527	CcSEcCtD
Voriconazole—Hepatomegaly—Lamivudine—hepatitis B	0.00409	0.00522	CcSEcCtD
Voriconazole—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00409	0.00522	CcSEcCtD
Voriconazole—CYP2B6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00403	0.0223	CbGpPWpGaD
Voriconazole—Throat sore—Lamivudine—hepatitis B	0.00402	0.00513	CcSEcCtD
Voriconazole—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00398	0.00508	CcSEcCtD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00393	0.0218	CbGpPWpGaD
Voriconazole—Renal impairment—Telbivudine—hepatitis B	0.00392	0.005	CcSEcCtD
Voriconazole—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00391	0.00499	CcSEcCtD
Voriconazole—Pancreatitis—Entecavir—hepatitis B	0.00385	0.00491	CcSEcCtD
Voriconazole—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00375	0.00479	CcSEcCtD
Voriconazole—CYP2C19—blood plasma—hepatitis B	0.00358	0.0994	CbGeAlD
Voriconazole—FMO1—Metapathway biotransformation—AKR1B1—hepatitis B	0.00354	0.0197	CbGpPWpGaD
Voriconazole—Hyperglycaemia—Entecavir—hepatitis B	0.00354	0.00452	CcSEcCtD
Voriconazole—FMO1—Biological oxidations—GGT2—hepatitis B	0.00344	0.0191	CbGpPWpGaD
Voriconazole—CYP3A7—Xenobiotics—CYP2A6—hepatitis B	0.00337	0.0187	CbGpPWpGaD
Voriconazole—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00336	0.00429	CcSEcCtD
Voriconazole—Haematuria—Entecavir—hepatitis B	0.00334	0.00426	CcSEcCtD
Voriconazole—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00333	0.00425	CcSEcCtD
Voriconazole—Hepatobiliary disease—Entecavir—hepatitis B	0.00331	0.00422	CcSEcCtD
Voriconazole—Muscular weakness—Telbivudine—hepatitis B	0.00329	0.0042	CcSEcCtD
Voriconazole—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00329	0.0042	CcSEcCtD
Voriconazole—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00326	0.00415	CcSEcCtD
Voriconazole—Abdominal distension—Telbivudine—hepatitis B	0.00325	0.00414	CcSEcCtD
Voriconazole—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00323	0.00412	CcSEcCtD
Voriconazole—Influenza—Telbivudine—hepatitis B	0.00322	0.00411	CcSEcCtD
Voriconazole—Rectal haemorrhage—Lamivudine—hepatitis B	0.00321	0.00409	CcSEcCtD
Voriconazole—Bone disorder—Lamivudine—hepatitis B	0.00321	0.00409	CcSEcCtD
Voriconazole—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0032	0.00409	CcSEcCtD
Voriconazole—Oropharyngeal pain—Lamivudine—hepatitis B	0.00318	0.00406	CcSEcCtD
Voriconazole—Hepatitis—Entecavir—hepatitis B	0.00314	0.00401	CcSEcCtD
Voriconazole—Drug interaction—Lamivudine—hepatitis B	0.00312	0.00398	CcSEcCtD
Voriconazole—Oedema peripheral—Entecavir—hepatitis B	0.00309	0.00395	CcSEcCtD
Voriconazole—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00306	0.00391	CcSEcCtD
Voriconazole—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00306	0.00391	CcSEcCtD
Voriconazole—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00304	0.0169	CbGpPWpGaD
Voriconazole—Hearing impaired—Lamivudine—hepatitis B	0.00304	0.00388	CcSEcCtD
Voriconazole—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00304	0.00388	CcSEcCtD
Voriconazole—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00303	0.00386	CcSEcCtD
Voriconazole—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00301	0.00384	CcSEcCtD
Voriconazole—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.003	0.00383	CcSEcCtD
Voriconazole—Inflammation—Lamivudine—hepatitis B	0.00299	0.00381	CcSEcCtD
Voriconazole—Immune system disorder—Entecavir—hepatitis B	0.00284	0.00362	CcSEcCtD
Voriconazole—CYP3A5—blood plasma—hepatitis B	0.00282	0.0783	CbGeAlD
Voriconazole—Neuropathy peripheral—Telbivudine—hepatitis B	0.00282	0.00359	CcSEcCtD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00281	0.0156	CbGpPWpGaD
Voriconazole—CYP2B6—blood plasma—hepatitis B	0.0028	0.0778	CbGeAlD
Voriconazole—Alopecia—Entecavir—hepatitis B	0.00278	0.00354	CcSEcCtD
Voriconazole—CYP2C9—blood plasma—hepatitis B	0.00278	0.0771	CbGeAlD
Voriconazole—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00277	0.0154	CbGpPWpGaD
Voriconazole—Mental disorder—Entecavir—hepatitis B	0.00275	0.00351	CcSEcCtD
Voriconazole—Malnutrition—Entecavir—hepatitis B	0.00273	0.00349	CcSEcCtD
Voriconazole—Aplastic anaemia—Lamivudine—hepatitis B	0.00272	0.00347	CcSEcCtD
Voriconazole—Neuropathy—Lamivudine—hepatitis B	0.00272	0.00347	CcSEcCtD
Voriconazole—Photophobia—Lamivudine—hepatitis B	0.00272	0.00347	CcSEcCtD
Voriconazole—Hepatobiliary disease—Telbivudine—hepatitis B	0.00272	0.00347	CcSEcCtD
Voriconazole—FMO1—liver—hepatitis B	0.00269	0.0746	CbGeAlD
Voriconazole—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00267	0.0034	CcSEcCtD
Voriconazole—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00263	0.00335	CcSEcCtD
Voriconazole—Mouth ulceration—Lamivudine—hepatitis B	0.00262	0.00334	CcSEcCtD
Voriconazole—Back pain—Adefovir Dipivoxil—hepatitis B	0.00258	0.00329	CcSEcCtD
Voriconazole—Hepatitis—Telbivudine—hepatitis B	0.00258	0.00329	CcSEcCtD
Voriconazole—Hypoaesthesia—Telbivudine—hepatitis B	0.00257	0.00328	CcSEcCtD
Voriconazole—Pharyngitis—Telbivudine—hepatitis B	0.00256	0.00327	CcSEcCtD
Voriconazole—Connective tissue disorder—Telbivudine—hepatitis B	0.00254	0.00324	CcSEcCtD
Voriconazole—PTGS1—blood plasma—hepatitis B	0.00253	0.0704	CbGeAlD
Voriconazole—FMO3—Metapathway biotransformation—AKR1B1—hepatitis B	0.00253	0.014	CbGpPWpGaD
Voriconazole—Sepsis—Lamivudine—hepatitis B	0.00251	0.00321	CcSEcCtD
Voriconazole—CYP2B6—Xenobiotics—CYP2A6—hepatitis B	0.0025	0.0139	CbGpPWpGaD
Voriconazole—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00247	0.00315	CcSEcCtD
Voriconazole—Lymphadenopathy—Lamivudine—hepatitis B	0.00246	0.00314	CcSEcCtD
Voriconazole—FMO3—Biological oxidations—GGT2—hepatitis B	0.00246	0.0137	CbGpPWpGaD
Voriconazole—Leukopenia—Entecavir—hepatitis B	0.00245	0.00312	CcSEcCtD
Voriconazole—Phlebitis—Lamivudine—hepatitis B	0.00244	0.00311	CcSEcCtD
Voriconazole—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	0.00244	0.0135	CbGpPWpGaD
Voriconazole—Gastroenteritis—Lamivudine—hepatitis B	0.00237	0.00303	CcSEcCtD
Voriconazole—Deafness—Lamivudine—hepatitis B	0.00235	0.003	CcSEcCtD
Voriconazole—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00235	0.013	CbGpPWpGaD
Voriconazole—Cough—Adefovir Dipivoxil—hepatitis B	0.00233	0.00297	CcSEcCtD
Voriconazole—Mediastinal disorder—Telbivudine—hepatitis B	0.00233	0.00297	CcSEcCtD
Voriconazole—FMO3—liver—hepatitis B	0.00232	0.0644	CbGeAlD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00231	0.00295	CcSEcCtD
Voriconazole—CYP3A7—liver—hepatitis B	0.0023	0.0637	CbGeAlD
Voriconazole—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00227	0.0029	CcSEcCtD
Voriconazole—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00227	0.0029	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00226	0.00288	CcSEcCtD
Voriconazole—Malnutrition—Telbivudine—hepatitis B	0.00225	0.00287	CcSEcCtD
Voriconazole—Anaphylactic shock—Entecavir—hepatitis B	0.00223	0.00285	CcSEcCtD
Voriconazole—Infection—Entecavir—hepatitis B	0.00222	0.00283	CcSEcCtD
Voriconazole—Renal impairment—Lamivudine—hepatitis B	0.00221	0.00282	CcSEcCtD
Voriconazole—PTGS1—Eicosanoid Synthesis—GGT1—hepatitis B	0.00221	0.0122	CbGpPWpGaD
Voriconazole—Dysgeusia—Telbivudine—hepatitis B	0.0022	0.00281	CcSEcCtD
Voriconazole—Nervous system disorder—Entecavir—hepatitis B	0.00219	0.00279	CcSEcCtD
Voriconazole—Back pain—Telbivudine—hepatitis B	0.00217	0.00277	CcSEcCtD
Voriconazole—Skin disorder—Entecavir—hepatitis B	0.00217	0.00277	CcSEcCtD
Voriconazole—Muscle spasms—Telbivudine—hepatitis B	0.00216	0.00276	CcSEcCtD
Voriconazole—Hypoglycaemia—Lamivudine—hepatitis B	0.00215	0.00275	CcSEcCtD
Voriconazole—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00214	0.00272	CcSEcCtD
Voriconazole—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00213	0.00272	CcSEcCtD
Voriconazole—CYP3A4—blood plasma—hepatitis B	0.00212	0.0588	CbGeAlD
Voriconazole—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00211	0.0027	CcSEcCtD
Voriconazole—FMO1—Biological oxidations—CYP2A6—hepatitis B	0.00209	0.0116	CbGpPWpGaD
Voriconazole—Ill-defined disorder—Telbivudine—hepatitis B	0.00208	0.00266	CcSEcCtD
Voriconazole—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00208	0.00265	CcSEcCtD
Voriconazole—Malaise—Telbivudine—hepatitis B	0.00203	0.00258	CcSEcCtD
Voriconazole—Insomnia—Entecavir—hepatitis B	0.00202	0.00258	CcSEcCtD
Voriconazole—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00198	0.011	CbGpPWpGaD
Voriconazole—Somnolence—Entecavir—hepatitis B	0.00198	0.00253	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00198	0.00253	CcSEcCtD
Voriconazole—Dyspepsia—Entecavir—hepatitis B	0.00196	0.00251	CcSEcCtD
Voriconazole—Cough—Telbivudine—hepatitis B	0.00196	0.0025	CcSEcCtD
Voriconazole—CYP3A7-CYP3A51P—liver—hepatitis B	0.00195	0.0542	CbGeAlD
Voriconazole—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00195	0.0108	CbGpPWpGaD
Voriconazole—Liver function test abnormal—Lamivudine—hepatitis B	0.00194	0.00248	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Entecavir—hepatitis B	0.00193	0.00246	CcSEcCtD
Voriconazole—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00192	0.00245	CcSEcCtD
Voriconazole—Arthralgia—Telbivudine—hepatitis B	0.00191	0.00244	CcSEcCtD
Voriconazole—Myalgia—Telbivudine—hepatitis B	0.00191	0.00244	CcSEcCtD
Voriconazole—Chest pain—Telbivudine—hepatitis B	0.00191	0.00244	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0019	0.00242	CcSEcCtD
Voriconazole—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00189	0.00242	CcSEcCtD
Voriconazole—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00189	0.00241	CcSEcCtD
Voriconazole—Discomfort—Telbivudine—hepatitis B	0.00189	0.00241	CcSEcCtD
Voriconazole—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.00189	0.0105	CbGpPWpGaD
Voriconazole—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00188	0.0024	CcSEcCtD
Voriconazole—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00185	0.00237	CcSEcCtD
Voriconazole—Muscular weakness—Lamivudine—hepatitis B	0.00185	0.00237	CcSEcCtD
Voriconazole—Abdominal distension—Lamivudine—hepatitis B	0.00183	0.00233	CcSEcCtD
Voriconazole—Gastrointestinal pain—Entecavir—hepatitis B	0.00182	0.00233	CcSEcCtD
Voriconazole—Dysphagia—Lamivudine—hepatitis B	0.00182	0.00232	CcSEcCtD
Voriconazole—Influenza—Lamivudine—hepatitis B	0.00182	0.00232	CcSEcCtD
Voriconazole—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00181	0.0101	CbGpPWpGaD
Voriconazole—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00181	0.0101	CbGpPWpGaD
Voriconazole—Nervous system disorder—Telbivudine—hepatitis B	0.0018	0.00229	CcSEcCtD
Voriconazole—Thrombocytopenia—Telbivudine—hepatitis B	0.00179	0.00229	CcSEcCtD
Voriconazole—Pancreatitis—Lamivudine—hepatitis B	0.00178	0.00227	CcSEcCtD
Voriconazole—Skin disorder—Telbivudine—hepatitis B	0.00178	0.00227	CcSEcCtD
Voriconazole—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00178	0.00227	CcSEcCtD
Voriconazole—Body temperature increased—Entecavir—hepatitis B	0.00176	0.00225	CcSEcCtD
Voriconazole—Abdominal pain—Entecavir—hepatitis B	0.00176	0.00225	CcSEcCtD
Voriconazole—Pancytopenia—Lamivudine—hepatitis B	0.00173	0.0022	CcSEcCtD
Voriconazole—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00172	0.0022	CcSEcCtD
Voriconazole—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00172	0.0022	CcSEcCtD
Voriconazole—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.00172	0.00954	CbGpPWpGaD
Voriconazole—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00171	0.00951	CbGpPWpGaD
Voriconazole—Dysuria—Lamivudine—hepatitis B	0.0017	0.00217	CcSEcCtD
Voriconazole—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00168	0.0093	CbGpPWpGaD
Voriconazole—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00167	0.00213	CcSEcCtD
Voriconazole—Insomnia—Telbivudine—hepatitis B	0.00166	0.00212	CcSEcCtD
Voriconazole—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00165	0.00918	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.00165	0.00916	CbGpPWpGaD
Voriconazole—Paraesthesia—Telbivudine—hepatitis B	0.00165	0.0021	CcSEcCtD
Voriconazole—Hyperglycaemia—Lamivudine—hepatitis B	0.00164	0.00209	CcSEcCtD
Voriconazole—FMO1—Biological oxidations—GGT1—hepatitis B	0.00163	0.00904	CbGpPWpGaD
Voriconazole—Depression—Lamivudine—hepatitis B	0.00162	0.00206	CcSEcCtD
Voriconazole—Dyspepsia—Telbivudine—hepatitis B	0.00161	0.00206	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00161	0.00205	CcSEcCtD
Voriconazole—Asthenia—Entecavir—hepatitis B	0.0016	0.00204	CcSEcCtD
Voriconazole—Neuropathy peripheral—Lamivudine—hepatitis B	0.00159	0.00203	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00158	0.00202	CcSEcCtD
Voriconazole—Stomatitis—Lamivudine—hepatitis B	0.00158	0.00201	CcSEcCtD
Voriconazole—Jaundice—Lamivudine—hepatitis B	0.00158	0.00201	CcSEcCtD
Voriconazole—Pain—Telbivudine—hepatitis B	0.00157	0.002	CcSEcCtD
Voriconazole—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00156	0.00199	CcSEcCtD
Voriconazole—Sweating—Lamivudine—hepatitis B	0.00155	0.00198	CcSEcCtD
Voriconazole—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00154	0.00197	CcSEcCtD
Voriconazole—Hepatobiliary disease—Lamivudine—hepatitis B	0.00153	0.00195	CcSEcCtD
Voriconazole—Epistaxis—Lamivudine—hepatitis B	0.00153	0.00195	CcSEcCtD
Voriconazole—Diarrhoea—Entecavir—hepatitis B	0.00153	0.00195	CcSEcCtD
Voriconazole—Sinusitis—Lamivudine—hepatitis B	0.00152	0.00194	CcSEcCtD
Voriconazole—Agranulocytosis—Lamivudine—hepatitis B	0.00151	0.00193	CcSEcCtD
Voriconazole—Feeling abnormal—Telbivudine—hepatitis B	0.00151	0.00193	CcSEcCtD
Voriconazole—Gastrointestinal pain—Telbivudine—hepatitis B	0.0015	0.00191	CcSEcCtD
Voriconazole—FMO3—Biological oxidations—CYP2A6—hepatitis B	0.00149	0.00827	CbGpPWpGaD
Voriconazole—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00149	0.0019	CcSEcCtD
Voriconazole—Dizziness—Entecavir—hepatitis B	0.00148	0.00188	CcSEcCtD
Voriconazole—Rhinitis—Lamivudine—hepatitis B	0.00146	0.00186	CcSEcCtD
Voriconazole—Hepatitis—Lamivudine—hepatitis B	0.00145	0.00186	CcSEcCtD
Voriconazole—Body temperature increased—Telbivudine—hepatitis B	0.00145	0.00185	CcSEcCtD
Voriconazole—Abdominal pain—Telbivudine—hepatitis B	0.00145	0.00185	CcSEcCtD
Voriconazole—Hypoaesthesia—Lamivudine—hepatitis B	0.00145	0.00185	CcSEcCtD
Voriconazole—Pharyngitis—Lamivudine—hepatitis B	0.00144	0.00184	CcSEcCtD
Voriconazole—Connective tissue disorder—Lamivudine—hepatitis B	0.00143	0.00182	CcSEcCtD
Voriconazole—Vomiting—Entecavir—hepatitis B	0.00142	0.00181	CcSEcCtD
Voriconazole—Rash—Entecavir—hepatitis B	0.00141	0.0018	CcSEcCtD
Voriconazole—Dermatitis—Entecavir—hepatitis B	0.00141	0.00179	CcSEcCtD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.0014	0.00778	CbGpPWpGaD
Voriconazole—Headache—Entecavir—hepatitis B	0.0014	0.00178	CcSEcCtD
Voriconazole—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00138	0.00177	CcSEcCtD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00138	0.00768	CbGpPWpGaD
Voriconazole—Erythema multiforme—Lamivudine—hepatitis B	0.00138	0.00175	CcSEcCtD
Voriconazole—Rash—Adefovir Dipivoxil—hepatitis B	0.00137	0.00175	CcSEcCtD
Voriconazole—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00137	0.00175	CcSEcCtD
Voriconazole—Headache—Adefovir Dipivoxil—hepatitis B	0.00136	0.00174	CcSEcCtD
Voriconazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00136	0.00752	CbGpPWpGaD
Voriconazole—Nausea—Entecavir—hepatitis B	0.00133	0.00169	CcSEcCtD
Voriconazole—Asthenia—Telbivudine—hepatitis B	0.00132	0.00168	CcSEcCtD
Voriconazole—Immune system disorder—Lamivudine—hepatitis B	0.00131	0.00168	CcSEcCtD
Voriconazole—CYP2C19—blood—hepatitis B	0.00131	0.0364	CbGeAlD
Voriconazole—Mediastinal disorder—Lamivudine—hepatitis B	0.00131	0.00167	CcSEcCtD
Voriconazole—Chills—Lamivudine—hepatitis B	0.0013	0.00166	CcSEcCtD
Voriconazole—Pruritus—Telbivudine—hepatitis B	0.0013	0.00165	CcSEcCtD
Voriconazole—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0013	0.00719	CbGpPWpGaD
Voriconazole—Nausea—Adefovir Dipivoxil—hepatitis B	0.00129	0.00165	CcSEcCtD
Voriconazole—Alopecia—Lamivudine—hepatitis B	0.00129	0.00164	CcSEcCtD
Voriconazole—Erythema—Lamivudine—hepatitis B	0.00127	0.00162	CcSEcCtD
Voriconazole—Malnutrition—Lamivudine—hepatitis B	0.00127	0.00162	CcSEcCtD
Voriconazole—Diarrhoea—Telbivudine—hepatitis B	0.00125	0.0016	CcSEcCtD
Voriconazole—Flatulence—Lamivudine—hepatitis B	0.00125	0.00159	CcSEcCtD
Voriconazole—Dysgeusia—Lamivudine—hepatitis B	0.00124	0.00158	CcSEcCtD
Voriconazole—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.00123	0.00681	CbGpPWpGaD
Voriconazole—Back pain—Lamivudine—hepatitis B	0.00122	0.00156	CcSEcCtD
Voriconazole—Muscle spasms—Lamivudine—hepatitis B	0.00122	0.00155	CcSEcCtD
Voriconazole—Dizziness—Telbivudine—hepatitis B	0.00121	0.00155	CcSEcCtD
Voriconazole—Tremor—Lamivudine—hepatitis B	0.00119	0.00151	CcSEcCtD
Voriconazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00118	0.00655	CbGpPWpGaD
Voriconazole—Ill-defined disorder—Lamivudine—hepatitis B	0.00117	0.0015	CcSEcCtD
Voriconazole—Anaemia—Lamivudine—hepatitis B	0.00117	0.00149	CcSEcCtD
Voriconazole—Vomiting—Telbivudine—hepatitis B	0.00117	0.00149	CcSEcCtD
Voriconazole—FMO3—Biological oxidations—GGT1—hepatitis B	0.00116	0.00646	CbGpPWpGaD
Voriconazole—Angioedema—Lamivudine—hepatitis B	0.00116	0.00148	CcSEcCtD
Voriconazole—Rash—Telbivudine—hepatitis B	0.00116	0.00147	CcSEcCtD
Voriconazole—Dermatitis—Telbivudine—hepatitis B	0.00115	0.00147	CcSEcCtD
Voriconazole—Headache—Telbivudine—hepatitis B	0.00115	0.00147	CcSEcCtD
Voriconazole—Malaise—Lamivudine—hepatitis B	0.00114	0.00146	CcSEcCtD
Voriconazole—Vertigo—Lamivudine—hepatitis B	0.00114	0.00145	CcSEcCtD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00114	0.0063	CbGpPWpGaD
Voriconazole—Syncope—Lamivudine—hepatitis B	0.00114	0.00145	CcSEcCtD
Voriconazole—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00113	0.00629	CbGpPWpGaD
Voriconazole—Leukopenia—Lamivudine—hepatitis B	0.00113	0.00145	CcSEcCtD
Voriconazole—Loss of consciousness—Lamivudine—hepatitis B	0.00111	0.00142	CcSEcCtD
Voriconazole—Cough—Lamivudine—hepatitis B	0.0011	0.00141	CcSEcCtD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.0011	0.00611	CbGpPWpGaD
Voriconazole—Convulsion—Lamivudine—hepatitis B	0.0011	0.0014	CcSEcCtD
Voriconazole—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00109	0.00605	CbGpPWpGaD
Voriconazole—Nausea—Telbivudine—hepatitis B	0.00109	0.00139	CcSEcCtD
Voriconazole—Arthralgia—Lamivudine—hepatitis B	0.00108	0.00138	CcSEcCtD
Voriconazole—Chest pain—Lamivudine—hepatitis B	0.00108	0.00138	CcSEcCtD
Voriconazole—Myalgia—Lamivudine—hepatitis B	0.00108	0.00138	CcSEcCtD
Voriconazole—Anxiety—Lamivudine—hepatitis B	0.00107	0.00137	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00107	0.00137	CcSEcCtD
Voriconazole—Discomfort—Lamivudine—hepatitis B	0.00106	0.00136	CcSEcCtD
Voriconazole—Dry mouth—Lamivudine—hepatitis B	0.00105	0.00134	CcSEcCtD
Voriconazole—Confusional state—Lamivudine—hepatitis B	0.00104	0.00133	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00104	0.00576	CbGpPWpGaD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00104	0.00575	CbGpPWpGaD
Voriconazole—Anaphylactic shock—Lamivudine—hepatitis B	0.00103	0.00132	CcSEcCtD
Voriconazole—Oedema—Lamivudine—hepatitis B	0.00103	0.00132	CcSEcCtD
Voriconazole—CYP3A5—blood—hepatitis B	0.00103	0.0287	CbGeAlD
Voriconazole—CYP2B6—blood—hepatitis B	0.00103	0.0285	CbGeAlD
Voriconazole—Infection—Lamivudine—hepatitis B	0.00103	0.00131	CcSEcCtD
Voriconazole—CYP2C19—liver—hepatitis B	0.00103	0.0285	CbGeAlD
Voriconazole—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	0.00102	0.00569	CbGpPWpGaD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00102	0.00568	CbGpPWpGaD
Voriconazole—CYP2C9—blood—hepatitis B	0.00102	0.0282	CbGeAlD
Voriconazole—Shock—Lamivudine—hepatitis B	0.00102	0.0013	CcSEcCtD
Voriconazole—Nervous system disorder—Lamivudine—hepatitis B	0.00101	0.00129	CcSEcCtD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00101	0.00562	CbGpPWpGaD
Voriconazole—Thrombocytopenia—Lamivudine—hepatitis B	0.00101	0.00129	CcSEcCtD
Voriconazole—Skin disorder—Lamivudine—hepatitis B	0.001	0.00128	CcSEcCtD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.001	0.00555	CbGpPWpGaD
Voriconazole—Hyperhidrosis—Lamivudine—hepatitis B	0.000999	0.00127	CcSEcCtD
Voriconazole—CYP3A7—Biological oxidations—GGT2—hepatitis B	0.000996	0.00553	CbGpPWpGaD
Voriconazole—Anorexia—Lamivudine—hepatitis B	0.000985	0.00126	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—GGT2—hepatitis B	0.000966	0.00536	CbGpPWpGaD
Voriconazole—Hypotension—Lamivudine—hepatitis B	0.000965	0.00123	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000941	0.0012	CcSEcCtD
Voriconazole—Insomnia—Lamivudine—hepatitis B	0.000934	0.00119	CcSEcCtD
Voriconazole—PTGS1—blood—hepatitis B	0.000928	0.0258	CbGeAlD
Voriconazole—Paraesthesia—Lamivudine—hepatitis B	0.000928	0.00118	CcSEcCtD
Voriconazole—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000923	0.00512	CbGpPWpGaD
Voriconazole—Dyspnoea—Lamivudine—hepatitis B	0.000921	0.00118	CcSEcCtD
Voriconazole—Somnolence—Lamivudine—hepatitis B	0.000918	0.00117	CcSEcCtD
Voriconazole—Dyspepsia—Lamivudine—hepatitis B	0.000909	0.00116	CcSEcCtD
Voriconazole—Decreased appetite—Lamivudine—hepatitis B	0.000898	0.00115	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000892	0.00114	CcSEcCtD
Voriconazole—Pain—Lamivudine—hepatitis B	0.000884	0.00113	CcSEcCtD
Voriconazole—Constipation—Lamivudine—hepatitis B	0.000884	0.00113	CcSEcCtD
Voriconazole—Feeling abnormal—Lamivudine—hepatitis B	0.000851	0.00109	CcSEcCtD
Voriconazole—Gastrointestinal pain—Lamivudine—hepatitis B	0.000845	0.00108	CcSEcCtD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00084	0.00466	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.000836	0.00464	CbGpPWpGaD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000821	0.00456	CbGpPWpGaD
Voriconazole—Urticaria—Lamivudine—hepatitis B	0.000821	0.00105	CcSEcCtD
Voriconazole—Abdominal pain—Lamivudine—hepatitis B	0.000817	0.00104	CcSEcCtD
Voriconazole—Body temperature increased—Lamivudine—hepatitis B	0.000817	0.00104	CcSEcCtD
Voriconazole—CYP3A5—liver—hepatitis B	0.000808	0.0224	CbGeAlD
Voriconazole—CYP2B6—liver—hepatitis B	0.000803	0.0223	CbGeAlD
Voriconazole—CYP2C9—liver—hepatitis B	0.000795	0.0221	CbGeAlD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000783	0.00435	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.000781	0.00433	CbGpPWpGaD
Voriconazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000779	0.00432	CbGpPWpGaD
Voriconazole—CYP3A4—blood—hepatitis B	0.000775	0.0215	CbGeAlD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000773	0.00429	CbGpPWpGaD
Voriconazole—Hypersensitivity—Lamivudine—hepatitis B	0.000761	0.000971	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000758	0.00421	CbGpPWpGaD
Voriconazole—Asthenia—Lamivudine—hepatitis B	0.000741	0.000946	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000741	0.00411	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—GGT2—hepatitis B	0.000737	0.00409	CbGpPWpGaD
Voriconazole—Pruritus—Lamivudine—hepatitis B	0.000731	0.000933	CcSEcCtD
Voriconazole—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.00072	0.004	CbGpPWpGaD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000714	0.00396	CbGpPWpGaD
Voriconazole—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000707	0.00393	CbGpPWpGaD
Voriconazole—Diarrhoea—Lamivudine—hepatitis B	0.000707	0.000902	CcSEcCtD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000705	0.00391	CbGpPWpGaD
Voriconazole—Dizziness—Lamivudine—hepatitis B	0.000683	0.000872	CcSEcCtD
Voriconazole—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.000675	0.00374	CbGpPWpGaD
Voriconazole—Vomiting—Lamivudine—hepatitis B	0.000657	0.000838	CcSEcCtD
Voriconazole—Rash—Lamivudine—hepatitis B	0.000651	0.000831	CcSEcCtD
Voriconazole—Dermatitis—Lamivudine—hepatitis B	0.000651	0.00083	CcSEcCtD
Voriconazole—Headache—Lamivudine—hepatitis B	0.000647	0.000826	CcSEcCtD
Voriconazole—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000645	0.00358	CbGpPWpGaD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000635	0.00352	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—AKR1B1—hepatitis B	0.000614	0.00341	CbGpPWpGaD
Voriconazole—Nausea—Lamivudine—hepatitis B	0.000614	0.000783	CcSEcCtD
Voriconazole—CYP3A4—liver—hepatitis B	0.000606	0.0168	CbGeAlD
Voriconazole—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	0.000603	0.00335	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—GGT2—hepatitis B	0.000589	0.00327	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.000585	0.00325	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000579	0.00321	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000573	0.00318	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000557	0.00309	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000524	0.00291	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000522	0.0029	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000508	0.00282	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000508	0.00282	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.0005	0.00277	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—GGT1—hepatitis B	0.000471	0.00261	CbGpPWpGaD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000471	0.00261	CbGpPWpGaD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000465	0.00258	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—GGT1—hepatitis B	0.000457	0.00253	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—CYP2A6—hepatitis B	0.000446	0.00248	CbGpPWpGaD
Voriconazole—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000442	0.00245	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—AKR1B1—hepatitis B	0.000439	0.00244	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.000436	0.00242	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GGT2—hepatitis B	0.000421	0.00234	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.000415	0.0023	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000395	0.00219	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000387	0.00215	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000382	0.00212	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.000379	0.0021	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CYP2A6—hepatitis B	0.000357	0.00198	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—GGT1—hepatitis B	0.000348	0.00193	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000344	0.00191	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000341	0.00189	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000337	0.00187	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000335	0.00186	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—GOT2—hepatitis B	0.000323	0.00179	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000319	0.00177	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000315	0.00175	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000308	0.00171	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—GOT1—hepatitis B	0.000278	0.00155	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—GGT1—hepatitis B	0.000278	0.00155	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000263	0.00146	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CYP2A6—hepatitis B	0.000255	0.00141	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.000245	0.00136	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.00024	0.00133	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GOT2—hepatitis B	0.000231	0.00128	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000223	0.00124	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000203	0.00113	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000203	0.00113	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GGT1—hepatitis B	0.000199	0.0011	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GOT1—hepatitis B	0.000199	0.0011	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000198	0.0011	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—AKR1B1—hepatitis B	0.000178	0.000986	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000175	0.000973	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—AKR1B1—hepatitis B	0.000172	0.000956	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GGT2—hepatitis B	0.00017	0.000945	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GGT2—hepatitis B	0.000165	0.000916	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000158	0.000879	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—ALB—hepatitis B	0.000148	0.000822	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—AKR1B1—hepatitis B	0.000131	0.000729	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—AKR1B1—hepatitis B	0.000128	0.000713	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GGT2—hepatitis B	0.000126	0.000699	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GGT2—hepatitis B	0.000123	0.000683	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTEN—hepatitis B	0.000113	0.000627	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—ALB—hepatitis B	0.000106	0.000588	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CYP2A6—hepatitis B	0.000103	0.000573	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000101	0.000561	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP2A6—hepatitis B	0.0001	0.000555	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—AKR1B1—hepatitis B	9.93e-05	0.000551	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GGT2—hepatitis B	9.52e-05	0.000528	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GOT2—hepatitis B	9.33e-05	0.000518	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	9.33e-05	0.000518	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.22e-05	0.000512	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—AKR1B1—hepatitis B	9.05e-05	0.000502	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GOT2—hepatitis B	9.05e-05	0.000502	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GGT2—hepatitis B	8.68e-05	0.000482	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTEN—hepatitis B	8.08e-05	0.000448	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GOT1—hepatitis B	8.06e-05	0.000447	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GGT1—hepatitis B	8.06e-05	0.000447	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GGT1—hepatitis B	7.81e-05	0.000433	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GOT1—hepatitis B	7.81e-05	0.000433	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP2A6—hepatitis B	7.63e-05	0.000424	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP2A6—hepatitis B	7.46e-05	0.000414	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.12e-05	0.000395	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GOT2—hepatitis B	6.9e-05	0.000383	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GOT2—hepatitis B	6.75e-05	0.000374	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.97e-05	0.000331	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GOT1—hepatitis B	5.96e-05	0.000331	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GGT1—hepatitis B	5.96e-05	0.000331	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GGT1—hepatitis B	5.82e-05	0.000323	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GOT1—hepatitis B	5.82e-05	0.000323	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP2A6—hepatitis B	5.77e-05	0.00032	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GGT2—hepatitis B	5.72e-05	0.000318	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.38e-05	0.000298	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP2A6—hepatitis B	5.26e-05	0.000292	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GOT2—hepatitis B	5.22e-05	0.000289	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.9e-05	0.000272	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GOT2—hepatitis B	4.76e-05	0.000264	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GGT1—hepatitis B	4.5e-05	0.00025	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GOT1—hepatitis B	4.5e-05	0.00025	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—ALB—hepatitis B	4.29e-05	0.000238	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—ALB—hepatitis B	4.15e-05	0.000231	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GOT1—hepatitis B	4.11e-05	0.000228	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GGT1—hepatitis B	4.11e-05	0.000228	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.1e-05	0.000228	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.74e-05	0.000208	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.47e-05	0.000192	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTEN—hepatitis B	3.27e-05	0.000181	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTEN—hepatitis B	3.17e-05	0.000176	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—ALB—hepatitis B	3.17e-05	0.000176	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GOT2—hepatitis B	3.14e-05	0.000174	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—ALB—hepatitis B	3.1e-05	0.000172	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GOT1—hepatitis B	2.71e-05	0.00015	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GGT1—hepatitis B	2.71e-05	0.00015	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTEN—hepatitis B	2.42e-05	0.000134	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—ALB—hepatitis B	2.4e-05	0.000133	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTEN—hepatitis B	2.36e-05	0.000131	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—ALB—hepatitis B	2.18e-05	0.000121	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTEN—hepatitis B	1.83e-05	0.000101	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTEN—hepatitis B	1.67e-05	9.25e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—ALB—hepatitis B	1.44e-05	7.99e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTEN—hepatitis B	1.1e-05	6.1e-05	CbGpPWpGaD
